The MedStar Health Research Institute utilizes Clinical Biosafety Services for Institutional Biosafety Committee (IBC) review. The IBC reviews and monitors all research activities involving infectious agents, hazardous chemicals, recombinant DNA, and genetically altered organisms and agents.
Biohazards are defined as biological agents and materials which are potentially hazardous to humans, animals and other forms of life. They include known pathogens and infectious agents including bacteria and their plasmids and phages, viruses, fungi, mycoplasmas, and parasites. Also included are potentially biohazardous organisms used in procedures such as recombinant DNA and genetic manipulations. Biohazards are to be classified according to risk levels requiring appropriate containment.
To submit your study for IBC review, please contact Clinical Biosafety Services at [email protected]